TFAP2A and breast carcinoma: We found that TFAP2A is one of the factors that contribute most significantly to mRNA-level expression changes that take place during embryonic stem cell (ESC) differentiation to mesoderm or to NC cells, during normal mammary gland development, and most importantly, in breast cancer models.